Multimodal therapy for squamous carcinoma of the oesophagus

British Journal of Surgery

Volumn 86, Issue 6, 1999, Pages 727-739

  Lehnert, T ^a  

^a UNIVERSITY OF HEIDELBERG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; CISPLATIN; FLUOROURACIL; VINDESINE;

ARTICLE; CANCER ADJUVANT THERAPY; CANCER STAGING; CANCER SURVIVAL; CLINICAL TRIAL; ESOPHAGUS CARCINOMA; HUMAN; META ANALYSIS; PRIORITY JOURNAL; PROGNOSIS; SQUAMOUS CELL CARCINOMA; SURGICAL MORTALITY;

CARCINOMA, SQUAMOUS CELL; CHEMOTHERAPY, ADJUVANT; ESOPHAGEAL NEOPLASMS; HUMANS; NEOPLASM STAGING; PROGNOSIS; RADIOTHERAPY, ADJUVANT; RANDOMIZED CONTROLLED TRIALS;

EID: 0033011013     PISSN: 00071323     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2168.1999.01152.x     Document Type: Article

References (69)

1. Earlam R, Cunha-Melo JR. Oesophageal squamous cell carcinoma: I. A critical review of surgery. Br J Surg 1980; 67: 381-90.
2. Müller JM, Erasmi H, Stelzner M, Zieren U, Pichlmaier H. Surgical therapy of oesophageal carcinoma. Br J Surg 1990; 77: 845-57.
3. Matthews HR, Powell DJ, McConkey CC. Effect of surgical experience on the results of resection for oesophageal carcinoma. Br J Surg 1986; 73: 621-3.
4. Jauch KW, Bacha EA, Denecke H, Anthuber M, Schildberg FW. Esophageal carcinoma: prognostic features and comparison between blunt transhiatal dissection and transthoracic resection. Eur J Surg Oncol 1992; 18: 553-62.
5. Roder JD, Busch R, Stein HJ, Fink U, Siewert JR. Ratio of invaded to removed lymph nodes as a predictor of survival in squamous cell carcinoma of the oesophagus. Br J Surg 1994; 81: 410-13.
6. Akiyama H, Tsurumaru M, Udagawa H, Kajiyama Y. Radical lymph node dissection for cancer of the thoracic esophagus. Ann Surg 1994; 220: 364-73.
7. 0) squamous cell carcinoma of the thoracic esophagus: final report on 163 consecutive patients with 5-year follow-up. Ann Surg 1997; 226: 714-24.
8. Altorki N, Skinner DB. En bloc esophagectomy for esophageal cancer: a superior method for local control. Proceedings of the American Society of Clinical Oncology 1997; 16: A995.
9. Murray GD. Meta-analysis. Br J Surg 1990; 77: 243-4.
10. Fok M, McShane J, Law SYK, Wong J. Prospective randomized study of radiotherapy and surgery in the treatment of oesophageal carcinoma. Asian Journal of Surgery 1994; 17: 223-9.
11. Kunath U, Fischer P. Radikalität und Lebenserwartung beim operierten Ösophagus- und Cardiakarzinom. Dtsch Med Wochenschr 1984; 109: 450-3.
12. Teniere P, Hay JM, Fingerhut A, Fagniez PL. Postoperative radiation therapy does not increase survival after curative resection for squamous cell carcinoma of the middle and lower esophagus as shown by a multicenter controlled trial. French University Association for Surgical Research. Surgery 1991; 173: 123-30.
13. Fok M, Sham JST, Choy D, Cheng SWK, Wong J. Postoperative radiotherapy for carcinoma of the esophagus: a prospective, randomized controlled study. Surgery 1993; 113: 138-47.
14. Zieren HU, Müller JM, Jacobi CA, Pichlmaier H, Müller RP, Staar S. Adjuvant postoperative radiation therapy after curative resection of squamous cell carcinoma of the thoracic esophagus: a prospective randomized study. World J Surg 1995; 19: 444-9.
15. Japanese Esophageal Oncology Group. A comparison of chemotherapy and radiotherapy as adjuvant treatment to surgery for esophageal carcinoma. Chest 1993; 104: 203-7.
16. Kakegawa T, Yamana H, Fujita H, Shinozaki K. Surgical adjuvant therapy of carcinoma of the thoracic esophagus. Can To Kagaku Ryobo 1993; 20: 1173-8.
17. Arimoto T, Takamura A, Tomita M, Suzuki K, Hosokawa M, Kaneko Y. Intraoperative radiotherapy for esophageal carcinoma - significance of IORT dose for the incidence of fatal tracheal complication. Int J Radiat Oncol Biol Phys 1993; 27: 1063-7.
18. Kim JP, Kwon OJ, Oh ST, Yang HK. Results of surgery on 6589 gastric cancer patients and immunochemosurgery as the best treatment of advanced gastric cancer. Ann Surg 1992; 216: 269-79.
19. Moertel CG, Fleming TR, Macdonald JS, Haller DG, Laurie JA, Tangen CM et al. Fluorouracil plus levamisole as effective adjuvant therapy after resection of stage III colon carcinoma: a final report. Ann Intern Med 1995; 122: 321-6.
20. Ochiai T, Sato H, Hayashi R, Asano T, Sato H, Yamamura Y. Postoperative adjuvant immunotherapy of gastric cancer with BCG-cell wall skeleton. 3- to 6-year follow-up of a randomized clinical trial. Cancer Immunol Immunother 1983; 14: 167-71.
21. Ogoshi K, Satou H, Isono K, Mitomi T, Endoh M, Sugita M. Possible predictive markers of immunotherapy in esophageal cancer: retrospective analysis of a randomized study. The Cooperative Study Group for Esophageal Cancer in Japan. Cancer Invest 1995; 13: 363-9.
22. Ogoshi K, Satou H, Isono K, Mitomi T, Endoh M, Sugita M. Immunotherapy for esophageal cancer. A randomized trial in combination with radiotherapy and radiochemotherapy. Am J Clin Oncol 1995; 18: 216-22.
23. Pouliquen X, Levard H, HayJM, McGee K, Fingerhut A, Langlois-Zantin O. 5-Fluorouracil and cisplatin therapy after palliative surgical resection of squamous cell carcinoma of the esophagus. Ann Surg 1996; 223: 127-33.
24. Ando N, Iizuka T, Kakegawa T, Isono K, Watanabe H, Ide H et al. A randomized trial of surgery with and without chemotherapy for localized squamous carcinoma of the thoracic esophagus: the Japan Clinical Oncology Group Study. J Thorac Cardiovasc Surg 1997; 114: 205-9.
25. Launois B, Delarue D, Campion JP, Kerbaol M. Preoperative radiotherapy for carcinoma of the esophagus. Surg Gynecol Obstet 1981; 153: 690-2.
26. Gignoux M, Roussel A, Paillot B, Gillet M, Schlag P, Favre JP et al. The value of preoperative radiotherapy in esophageal cancer: results of a study of the EORTC. World J Surg 1987; 11: 426-32.
27. Wang M, Gu XZ, Yin WB, Huang GJ, Wang LJ, Zhang DW. Randomized clinical trial on the combination of preoperative irradiation and surgery in the treatment of esophageal carcinoma: report on 206 patients. Int J Radiat Oncol Biol Phys 1989; 16: 325-7.
28. Arnott SJ, Duncan W, Kerr GR, Walbaum PR, Cameron E, Jack WJ et al. Low dose preoperative radiotherapy for carcinoma of the oesophagus: results of a randomized clinical trial. Radiother Oncol 1992; 24: 108-13.
29. Earlam R. An MRC prospective randomised trial of radiotherapy versus surgery for operable squamous cell carcinoma of the oesophagus. Ann R Coll Surg 1991; 73: 8-12.
30. Iizuka T, Ide H, Kakegawa T, Sasaki K, Takagi I, Ando N et al. Preoperative radioactive therapy for esophageal carcinoma. Randomized evaluation trial in eight institutions. Chest 1988; 93: 1054-8.
31. Kelsen DP, Minsky B, Smith M, Beitler J, Niedzwiecki D, Chapman D et al. Preoperative therapy for esophageal cancer: a randomized comparison of chemotherapy versus radiation therapy. J Clin Oncol 1990; 8: 1352-61.
32. Sischy B, Ryan L, Haller D, Smith T, Dayal Y, Schutt A et al. Interim report of EST 1282 phase III protocol for the evaluation of combined modalities in the treatment of patients with carcinoma of the esophagus. Proceedings of the American Society of Clinical Oncology 1990; 9: A407.
33. Zhao Y, Wie G, Sha Y. A randomized clinical study of preoperative accelerated radiotherapy versus routine radiotherapy for late esophageal cancers - an analysis of 177 cases. Chinese Journal of Oncology 1994; 16: 444-6.
34. Roth JA, Pass HI, Flanagan MM, Graeber GM, Rosenberg JC, Steinberg S. Randomized clinical trial of preoperative and postoperative adjuvant chemotherapy with cisplatin, vindesine, and bleomycin for carcinoma of the esophagus. J Thorac Cardiovasc Surg 1988; 96: 242-8.
35. Nygaard K, Hagen S, Hansen HS, Hatlevoll R, Hultborn R, Jakobsen A et al. Pre-operative radiotherapy prolongs survival in operable esophageal carcinoma: a randomized, multicenter study of pre-operative radiotherapy and chemotherapy. The second Scandinavian trial in esophageal cancer. World J Surg 1992; 16: 1104-10.
36. Schlag P. Randomized trial of preoperative chemotherapy for squamous cell cancer of the esophagus. The Chirurgische Arbeitsgemeinschaft fuer Onkologie der Deutschen Gesellschaft fuer Chirurgie Study Group. Arch Surg 1992; 127: 1446-50.
37. Maipang T, Vasinanukorn P, Petpichetchian C, Chamroonkul S, Geater A, Chansawwaang S et al. Induction chemotherapy in the treatment of patients with carcinoma of the esophagus. J Surg Oncol 1994; 56: 191-7.
38. 0) dell'esophago. Acta Chirurgica Italiana 1995; 51: 308-17.
39. Law S, Fok M, Chow S, Chu KM, Wong J. Preoperative chemotherapy versus surgical therapy alone for squamous cell carcinoma of the esophagus: a prospective randomized trial. J Thorac Cardivasc Surg 1997; 114: 210-17.
40. Kelsen DP, Ginsberg R, Qian C, Gunderson L, Mortimer J, Estes N et al. Chemotherapy followed by operation versus operation alone in the treatment of patients with localized esophageal cancer: a preliminary report of Intergroup study 113 (RTOG 89-11). Proceedings of the American Society of Clinical Oncology 1997; 17: 982.
41. Kok TC, van Lanschot J, Siersema PD, van Overhagen H, Tilanus HW. Neoadjuvant chemotherapy in operable squamous cell cancer: final report of a phase III multicenter randomised trial. Proceedings of the American Society of Clinical Oncology 1997; 17: 984.
42. Andersen AP, Berdal P, Edsmyr F, Hagen S, Hatlevoll R, Nygaard K et al. Irradiation, chemotherapy and surgery in esophageal cancer: a randomized clinical study. The first Scandinavian trial in esophageal cancer. Radiother Oncol 1984; 2: 179-88.
43. Leichman L, Steiger Z, Steydel HG, Dindogru A, Kinzie J, Toben S et al. Preoperative chemotherapy and radiation therapy for patients with cancer of the esophagus: a potentially curative approach. J Clin Oncol 1984; 2: 75-9.
44. Mathew G, Jamieson GG. Neoadjuvant therapy for oesophageal cancer. Br J Surg 1997; 84: 1185-7.
45. Vogel SB, Mendenhall WM, Sombeck MD, Marsh R, Woodward ER. Downstaging of esophageal cancer after preoperative radiation and chemotherapy. Ann Surg 1995; 221: 685-95.
46. Adelstein DJ, Rice TW, Becker M, Larto MA, Kirby TJ, Koka A et al. Use of concurrent chemotherapy, accelerated fractionation radiation and surgery for patients with esophageal carcinoma. Cancer 1997; 80: 1011-20.
47. Apinop C, Puttisak P, Preecha N. A prospective study of combined therapy in esophageal cancer. Hepatogastroenterology 1994; 41: 391-3.
48. Le Prise E, Etienne PL, Meunier B, Maddern G, Ben Hassel M, Gedouin D et al. A randomized study of chemotherapy, radiation therapy, and surgery venus surgery for localized squamous cell carcinoma of the esophagus. Cancer 1994; 73: 1779-84.
49. Bosset JF, Gignoux M, Triboulet JP, Tiret E, Mantinon G, Elias D et al. Chemoradiotherapy followed by surgery compared with surgery alone in squamous-cell cancer of the esophagus. N Engl J Med 1997; 337: 161-7.
50. Kitamura K, Kuwano H, Watanabe M, Nozoe T, Yasuda M, Sumiyoshi K et al. Prospective randomized study of hyperthermia combined with chemoradiotherapy for esophageal carcinoma. J Surg Oncol 1995; 60: 55-8.
51. Herskovic A, Martz K, Al-Sarraf M, Leichman L, Brindle J, Vaitkevicius V et al. Combined chemotherapy and radiotherapy compared with radiotherapy alone in patients with cancer of the esophagus. N Engl J Med 1992; 326: 1593-8.
52. Araujo CMM, Souhami L, Gil RA, Carvalho R, Garcia JA, Froimtchuk MJ et al. A randomized trial comparing radiation therapy versus concomitant radiation therapy and chemotherapy in carcinoma of the thoracic esophagus. Cancer 1991; 67: 2258-61.
53. Minsky BD, Neuberg D, Kelsen DP, Pisansky TM, Ginsberg R, Benson A III. Neoadjuvant chemotherapy plus concurrent chemotherapy and high-dose radiation for squamous cell carcinoma of the esophagus: a preliminary analysis of the phase II Intergroup trial 0122. J Clin Oncol 1996; 14: 149-55.
54. Fraunberger L, Kraus B, Dworak O. Verteilung der Lymphknoten und Lymphknotenmetastasen beim Ösophaguskarzinom. Zentralbl Chir 1996; 121: 102-5.
55. Union Internacional Contra la Cancrum. TNM Classification, 5th ed. Heidelberg: Springer, 1997.
56. Begg C, Cho M, Eastwood S, Horton R, Moher D, Olkin I et al. Improving the quality of reporting of randomized controlled trials. The CONSORT Statement. JAMA 1996; 276: 637-9.
57. Standards of Reporting Trials Group. A proposal for structured reporting of randomized controlled trials. JAMA 1994; 272: 1926-31.
58. Hölscher AH, Dittler HJ, Siewert JR. Staging of squamous esophageal cancer: accuracy and value. World J Surg 1994; 18: 312-20.
59. Huang GJ, Gu XZ, Wang LJ, Yin WB, Zhang RG, Zhang LJ et al. Experience with combined preoperative irradiation and surgery for carcinoma of the esophagus. GANN Monograph 1986; 31: 159-64.
60. Nishihira T, Hirayama K, Mori S. A prospective randomized trial of extended cervical and superior mediastinal lymphadenectomy for carcinoma of the thoracic esophagus. Arch Surg 1998; 175: 47-51.
61. Adelstein DJ, Rice TW, Becker M, Larto MA, Kirby TJ, Zuccaro G et al. Accelerated fractionation, concurrent cisplatin/paclitaxel chemotherapy and surgery for locoregionally advanced esophageal cancer. Proceedings of the American Society of Clinical Oncology 1997; 16: A924.
62. Meluch AA, Hainsworth JD, Thomas M, Stroup SL, Gray JR, Greco FA. Preoperative therapy with paclitaxel, carboplatin, 5-FU, and radiation yields 69 per cent pathologic complete response rate in the treatment of local esophageal carcinoma. Proceedings of the American Society of Clinical Oncology 1997; 16: A927.
63. Raoul JL, LePrise E, Meunier B, Heresbach D, Launois B. Neoadjuvant chemotherapy and hyperfractionated radiotherapy with concurrent low-dose chemotherapy for squamous cell esophageal carcinoma. Proceedings of the American Society of Clinical Oncology 1997; 16: A925.
64. Soto Parra H, Valente M, Bidoli P, Cantù G, Licitra L, Salvini PM et al. Definitive chemoradiotherapy in cervical esophageal carcinoma. Proceedings of the American Society of Clinical Oncology 1997; 16: A929.
65. Nozoe T, Kuwano H, Watanabe M, Yasuda M, Sadanaga N, Mimori K et al. The long-term results of pre-operative hyperthermo-chemo-radiotherapy for oesophageal carcinoma - a comparison with preoperative radiation therapy alone. Eur J Surg Oncol 1995; 21: 374-8.
66. Ribeiro U Jr, Finkelstein SD, Safatle-Ribeiro AV, Landreneau RJ, Clarke MR, Bakker A et al. p53 sequence analysis predicts treatment response and outcome of patients with esophageal carcinoma. Cancer 1998; 83: 7-18.
67. Couper GW, McAteer D, Wallis F, Norton M, Welch A, Nicholson M et al. Detection of response to chemotherapy using positron emission tomography in patients with oesophageal and gastric cancer. Br J Surg 1998; 85: 1403-6.
68. Urba S, Orringer M, Turrisi A, Whyte R, Iannettoni M, Forastiere A. A randomized trial comparing surgery to preoperative concomitant chemoradiation plus surgery in patients with resectable esophageal cancer: updated analysis. Proceedings of the American Society of Clinical Oncology 1997; 16: A983.
69. Walsh TN, Noonan N, Hollywood D, Kelly A, Keeling N, Hennessy TPJ. A comparison of multimodal therapy and surgery for esophageal adenocarcinoma. N Engl J Med 1996; 335: 462-7.